Lung and general health effects of Toll-like receptor-4 (TLR4)-interacting SPA4 peptide.

BMC Pulm Med · 2020 · PMC7310322 · PMID 32576172

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Similarly, the levels of other study parameters in SPA4 peptide-treated mice showed a trend towards the one noted in unchallenged, untreated mice.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.